Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page adds recruitment status text ('No longer looking for participants'), introduces new help and navigation sections, and updates the revision label, while a heading formatting change standardizes 'Intervention/Treatment'.
    Difference
    0.6%
    Check dated 2026-06-13T17:47:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5 and some related topics and an older revision tag were removed, indicating a minor metadata cleanup.
    Difference
    0.2%
    Check dated 2026-06-06T14:19:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now includes additional related topics and links: Melanoma and MedlinePlus Genetics. These additions provide extra context without altering the study details.
    Difference
    0.2%
    Check dated 2026-05-30T12:34:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Removed items from the related resources block, including the Melanoma entry, the 'related topics:' header, and the MedlinePlus Genetics link.
    Difference
    0.2%
    Check dated 2026-05-23T09:26:56.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed under related topics, and the page revision has been updated from v3.5.3 to v3.5.4.
    Difference
    0.2%
    Check dated 2026-05-15T23:19:58.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Removed related topics keywords, including Melanoma, related topics:, and MedlinePlus Genetics, from the page's metadata, reducing their associations with the study context and linked resources. This change pertains to tagging rather than the trial content itself.
    Difference
    0.2%
    Check dated 2026-05-08T23:39:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.